Could nutritional supplements act as therapeutic adjuvants in COVID-19?

Ital J Pediatr. 2021 Feb 15;47(1):32. doi: 10.1186/s13052-021-00990-0.

Abstract

Background: The role of the immune system and inflammatory response in the pathogenesis of the severe manifestations of coronavirus disease 2019 (COVID-19) is well known. Currently, different therapies active on the immune system are used for the management of COVID-19. The involvement of the immune system also opens the opportunity for the use of nutritional supplements with antimicrobial and immunomodulatory activity.

Main aspects: Nutritional supplements with antimicrobial and immunomodulatory activity are promising therapeutic adjuvants for the treatment of COVID-19, and also for the prevention of viral spreading. In particular, the role of vitamin D, probiotics, lactoferrin, and zinc is of significant clinical interest, although there are only a few data on their use in COVID-19 patients. Their molecular actions, together with the results of studies performed on other respiratory infections, strongly suggest their potential utility in COVID-19. This article discusses the main properties of these nutritional supplements and their potential applicability in the prevention and treatment of COVID-19.

Conclusion: The supplementation with vitamin D, probiotics, lactoferrin and zinc could have a role both in preventing SARS-CoV-2 infection and in mitigating the clinical course in infected patients, contributing in the prevention of immune-mediated organ damage.

Keywords: COVID-19; Cytokine storm; Immune system; Lactoferrin; Nutrition; Probiotics; Supplementation; Vitamin d; Zinc.

Publication types

  • Review

MeSH terms

  • COVID-19 / immunology*
  • COVID-19 Drug Treatment*
  • Dietary Supplements*
  • Humans
  • Lactoferrin / therapeutic use
  • Pandemics
  • Probiotics / therapeutic use
  • SARS-CoV-2
  • Vitamin D / therapeutic use
  • Zinc / therapeutic use

Substances

  • Vitamin D
  • Lactoferrin
  • Zinc